Abstract:OBJECTIVE To investigate the bioequivalence of risperidone tablets in healthy volunteers.METHODS 2 mg reference or test tablets were given to 22 healthy male volunteers in a randomized two-way crossover design.The concentrations of risperidone and 9-hydroxy-risperidone were determined by HPLC/MS.The bioequivalence of two formulations were investigated by the analysis of variance,two one side t-test and 90% confidence interval test.RESULTS The pharmacokinetic parameters of risperidone reference and test tablets were as follows:AUC_(0-t)(124.80±116.22) and(137.19±118.12) μg·h·L~(-1),ρ_(max)(17.00±6.87) and(19.24±7.63) μg·L~(-1),t_(max)(1.52±0.93) and(1.32±0.58) h,K_e(0.19±0.13) and(0.18±0.12) h~(-1),t_(1/2K_e)(7.58±8.72) and(6.31±4.65) h.The pharmacokinitic parameters of 9-hydroxy-risperidone were as follows:AUC_(0-t)(564.3±182.42) and(580.01±205.38) μg·h·L~(-1),ρ_(max)(20.00±9.84) and(20.05±10.38) μg·L~(-1),t_(max)(5.93±3.59) and(5.70±3.18) h,K_e(0.032±0.007 8) and(0.034±0.008 0) h~(-1),t_(1/2K_e)(23.15±6.07) and(21.50±4.62) h.The pharmacokinitic parameters of total active moiety were as follows:AUC_(0-t)(692.54±235.57) and(720.80±260.22) μg·h·L~(-1),ρ_(max)(32.00±9.42) and(33.89±13.02) μg·L~(-1),t_(max)(2.27±1.50) and(1.98±1.25) h,K_e(0.033±0.008 6) and(0.035±0.007 8) h~(-1),t_(1/2K_e)(22.72±6.94) and(20.98±4.34) h,respectively.The mean relative bioavailability of tested vs reference tablets were(113.4±25.85)%,(104.6±20.83)%,(105.4±19.64)% for risperidone,9-hydroxy-risperidone and total active moiety respectively.CONCLUSION The two formulations are bioequivalent.

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Pharmacokinetics and bioequivalence of domestic and imported ramipril tablets

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Indinavir Capsule in Healthy Volunteers

High-Performance Liquid Chromatography-Mass Spectrometric Analysis of Ramipril and Its Active Metabolite Ramiprilat in Human Serum: Application to A Pharmacokinetic Study in the Chinese Volunteers

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence evaluation of domestic tablets and imported capsules of rivastigmine tartrate

Studies on the Bioequivalence of Domestic Terazosin Tablet in Healthy Volunteers

Bioequivalence study of fluoxetine capsules in healthy volunteers

Bioequivalent Study of Citalopram Tablets

Study on Bioequivalence of Ambroxol Hydrochloride Tablets from Domestic and Import

Study on Bioequivalence of Risperidone Tablets

Pharmacokinetics and bioequivalence of roxithromycin capsules in healthy volunteers

Bioequivalence of domestic and imported bisoproloi tablets

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Pharmacokinetic and Relative Bioavailability of Losartan Potassium Tablet in Chinese Healthy Volunteers

Simultaneous Quantification of Ramipril and Ramiprilat in Drug Formulations: A Clinical LC-MS/MS Study